New insights into the role of adipokines in atrial fibrillation pathogenesis

FHS
June 14, 2024
2:34 pm

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Atrial fibrillation (AF) is a prevalent cardiac arrhythmia characterized by irregular and frequently rapid electrical activity in the atria.

Frontier Medicines raises $80M, enters clinic and eyes potential IPO in Q4 or early 2025

Frontier Medicines, a bicoastal biotech creating covalent small molecules, has secured $80 million in Series C funds and dosed the first patient in its initial

February 23, 2024

Optimi Health Completes Largest MDMA Capsule Batch to Date, Expands Stability Program | Psychedelic Invest

Vancouver, British Columbia–(Newsfile Corp. – January 29, 2025) – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimi” or the “Company”), a Canadian-based company

January 31, 2025

Drug wholesaler owners indicted for alleged role in diverting Gilead and J&J HIV medicines

The owners of a drug wholesaler have been indicted for their alleged role in a conspiracy to distribute misbranded and diverted HIV pills, the latest

June 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.